On Jan 22, 2021, Broadwood Partners, L.P. has been, and may continue to be, in contact with members of OncoCyte Corporation’s management, the board of directors of the Company, other significant shareholders and others regarding alternatives that the Company could employ to maximize the creation of shareholder value over time. Broadwood Partners further reserve the right to act in concert with any other shareholders of the Company, or other persons, for a common purpose should it determine to do so, and/or to recommend courses of action to shareholders, the board of directors and/or the management of the Company.